Polygenic risk scores for alzheimer’s disease are related to dementia risk in apoe ɛ4 negatives

Jenna Najar*, Sven J. van der Lee, Erik Joas, Hanna Wetterberg, John Hardy, Rita Guerreiro, Jose Bras, Margda Waern, Silke Kern, Henrik Zetterberg, Kaj Blennow, Ingmar Skoog, Anna Zettergren

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Introduction: Studies examining the effect of polygenic risk scores (PRS) for Alzheimer’s disease (AD) and apolipoprotein E (APOE) genotype on incident dementia in very old individuals are lacking. Methods: A population-based sample of 2052 individuals ages 70 to 111, from Swe-den, was followed in relation to dementia. AD-PRSs including 39, 57, 1333, and 13,942 single nucleotide polymorphisms (SNPs) were used. Results: AD-PRSs (including 39 or 57 SNPs) were associated with dementia (57-SNPs AD-PRS: hazard ratio 1.09, confidence interval 1.01–1.19, P = .03), particularly in APOE ɛ4 non-carriers (57-SNPs AD-PRS: 1.15, 1.05–1.27, P = 4 × 10–3, 39-SNPs AD-PRS: 1.22, 1.10–1.35, P = 2 × 10–4 ). No association was found with the other AD-PRSs. Further, APOE ɛ4 was associated with increased risk of dementia (1.60, 1.35–1.92, P = 1 × 10–7 ). In those aged ≥95 years, the results were similar for the AD-PRSs, while APOE ɛ4 only predicted dementia in the low-risk tertile of AD-PRSs. Discussion: These results provide information to identify individuals at increased risk of dementia.
Original languageEnglish
Article numbere12142
JournalAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Issue number1
Publication statusPublished - 2021

Cite this